INS and type 1 diabetes mellitus: For example, an acute injection of LPA at 50 mg/kg impairs insulin secretion and thereby reduces glucose clearance from the blood stream6, while another study reported that acute LPA injections between 3.3 and 6.6 mg/kg lowered blood glucose levels in the streptozotocin mouse model of type I diabetes that lacks insulin secretion8.